table of content
1 Introduction to Research & Analysis Reports
1.1 Pharmacogenomics Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacogenomics Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmacogenomics Services Overall Market Size
2.1 Global Pharmacogenomics Services Market Size: 2022 VS 2032
2.2 Global Pharmacogenomics Services Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmacogenomics Services Players in Global Market
3.2 Top Global Pharmacogenomics Services Companies Ranked by Revenue
3.3 Global Pharmacogenomics Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmacogenomics Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmacogenomics Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacogenomics Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmacogenomics Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacogenomics Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmacogenomics Services Market Size Markets, 2022 & 2032
4.1.2 Genotyping
4.1.3 SNP Identification
4.1.4 Pharmacogenetic Testing
4.1.5 Others
4.2 By Type - Global Pharmacogenomics Services Revenue & Forecasts
4.2.1 By Type - Global Pharmacogenomics Services Revenue, 2018-2023
4.2.2 By Type - Global Pharmacogenomics Services Revenue, 2024-2032
4.2.3 By Type - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmacogenomics Services Market Size, 2022 & 2032
5.1.2 Oncology
5.1.3 Infectious Diseases
5.1.4 Psychiatry
5.1.5 Cardiovascular
5.1.6 Others
5.2 By Application - Global Pharmacogenomics Services Revenue & Forecasts
5.2.1 By Application - Global Pharmacogenomics Services Revenue, 2018-2023
5.2.2 By Application - Global Pharmacogenomics Services Revenue, 2024-2032
5.2.3 By Application - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Pharmacogenomics Services Market Size, 2022 & 2032
6.2 By Region - Global Pharmacogenomics Services Revenue & Forecasts
6.2.1 By Region - Global Pharmacogenomics Services Revenue, 2018-2023
6.2.2 By Region - Global Pharmacogenomics Services Revenue, 2024-2032
6.2.3 By Region - Global Pharmacogenomics Services Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Pharmacogenomics Services Revenue, 2018-2032
6.3.2 US Pharmacogenomics Services Market Size, 2018-2032
6.3.3 Canada Pharmacogenomics Services Market Size, 2018-2032
6.3.4 Mexico Pharmacogenomics Services Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Pharmacogenomics Services Revenue, 2018-2032
6.4.2 Germany Pharmacogenomics Services Market Size, 2018-2032
6.4.3 France Pharmacogenomics Services Market Size, 2018-2032
6.4.4 U.K. Pharmacogenomics Services Market Size, 2018-2032
6.4.5 Italy Pharmacogenomics Services Market Size, 2018-2032
6.4.6 Russia Pharmacogenomics Services Market Size, 2018-2032
6.4.7 Nordic Countries Pharmacogenomics Services Market Size, 2018-2032
6.4.8 Benelux Pharmacogenomics Services Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Pharmacogenomics Services Revenue, 2018-2032
6.5.2 China Pharmacogenomics Services Market Size, 2018-2032
6.5.3 Japan Pharmacogenomics Services Market Size, 2018-2032
6.5.4 South Korea Pharmacogenomics Services Market Size, 2018-2032
6.5.5 Southeast Asia Pharmacogenomics Services Market Size, 2018-2032
6.5.6 India Pharmacogenomics Services Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Pharmacogenomics Services Revenue, 2018-2032
6.6.2 Brazil Pharmacogenomics Services Market Size, 2018-2032
6.6.3 Argentina Pharmacogenomics Services Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacogenomics Services Revenue, 2018-2032
6.7.2 Turkey Pharmacogenomics Services Market Size, 2018-2032
6.7.3 Israel Pharmacogenomics Services Market Size, 2018-2032
6.7.4 Saudi Arabia Pharmacogenomics Services Market Size, 2018-2032
6.7.5 UAE Pharmacogenomics Services Market Size, 2018-2032
7 Pharmacogenomics Services Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Pharmacogenomics Services Major Product Offerings
7.1.4 Abbott Laboratories Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Admera Health, LLC
7.2.1 Admera Health, LLC Company Summary
7.2.2 Admera Health, LLC Business Overview
7.2.3 Admera Health, LLC Pharmacogenomics Services Major Product Offerings
7.2.4 Admera Health, LLC Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.2.5 Admera Health, LLC Key News & Latest Developments
7.3 Mesa Laboratories, Inc.
7.3.1 Mesa Laboratories, Inc. Company Summary
7.3.2 Mesa Laboratories, Inc. Business Overview
7.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Major Product Offerings
7.3.4 Mesa Laboratories, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.3.5 Mesa Laboratories, Inc. Key News & Latest Developments
7.4 Dynamic DNA Laboratories
7.4.1 Dynamic DNA Laboratories Company Summary
7.4.2 Dynamic DNA Laboratories Business Overview
7.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Major Product Offerings
7.4.4 Dynamic DNA Laboratories Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.4.5 Dynamic DNA Laboratories Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 GeneOmbio Technologies Pvt Ltd.
7.6.1 GeneOmbio Technologies Pvt Ltd. Company Summary
7.6.2 GeneOmbio Technologies Pvt Ltd. Business Overview
7.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Major Product Offerings
7.6.4 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.6.5 GeneOmbio Technologies Pvt Ltd. Key News & Latest Developments
7.7 Exact Sciences Corporation
7.7.1 Exact Sciences Corporation Company Summary
7.7.2 Exact Sciences Corporation Business Overview
7.7.3 Exact Sciences Corporation Pharmacogenomics Services Major Product Offerings
7.7.4 Exact Sciences Corporation Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.7.5 Exact Sciences Corporation Key News & Latest Developments
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Company Summary
7.8.2 Illumina, Inc. Business Overview
7.8.3 Illumina, Inc. Pharmacogenomics Services Major Product Offerings
7.8.4 Illumina, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.8.5 Illumina, Inc. Key News & Latest Developments
7.9 Laboratory Corporation of America Holdings
7.9.1 Laboratory Corporation of America Holdings Company Summary
7.9.2 Laboratory Corporation of America Holdings Business Overview
7.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Major Product Offerings
7.9.4 Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.9.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.10 Myriad Genetics, Inc.
7.10.1 Myriad Genetics, Inc. Company Summary
7.10.2 Myriad Genetics, Inc. Business Overview
7.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Major Product Offerings
7.10.4 Myriad Genetics, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.10.5 Myriad Genetics, Inc. Key News & Latest Developments
7.11 OmeCare
7.11.1 OmeCare Company Summary
7.11.2 OmeCare Business Overview
7.11.3 OmeCare Pharmacogenomics Services Major Product Offerings
7.11.4 OmeCare Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.11.5 OmeCare Key News & Latest Developments
7.12 QIAGEN N.V.
7.12.1 QIAGEN N.V. Company Summary
7.12.2 QIAGEN N.V. Business Overview
7.12.3 QIAGEN N.V. Pharmacogenomics Services Major Product Offerings
7.12.4 QIAGEN N.V. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.12.5 QIAGEN N.V. Key News & Latest Developments
7.13 Quest Diagnostics Incorporated
7.13.1 Quest Diagnostics Incorporated Company Summary
7.13.2 Quest Diagnostics Incorporated Business Overview
7.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Major Product Offerings
7.13.4 Quest Diagnostics Incorporated Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.13.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.14 Thermo Fisher Scientific Inc.
7.14.1 Thermo Fisher Scientific Inc. Company Summary
7.14.2 Thermo Fisher Scientific Inc. Business Overview
7.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Major Product Offerings
7.14.4 Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.14.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.15 Precipio
7.15.1 Precipio Company Summary
7.15.2 Precipio Business Overview
7.15.3 Precipio Pharmacogenomics Services Major Product Offerings
7.15.4 Precipio Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.15.5 Precipio Key News & Latest Developments
7.16 23andMe, Inc.
7.16.1 23andMe, Inc. Company Summary
7.16.2 23andMe, Inc. Business Overview
7.16.3 23andMe, Inc. Pharmacogenomics Services Major Product Offerings
7.16.4 23andMe, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.16.5 23andMe, Inc. Key News & Latest Developments
7.17 OneOme, LLC
7.17.1 OneOme, LLC Company Summary
7.17.2 OneOme, LLC Business Overview
7.17.3 OneOme, LLC Pharmacogenomics Services Major Product Offerings
7.17.4 OneOme, LLC Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.17.5 OneOme, LLC Key News & Latest Developments
7.18 DiaCarta, Inc.
7.18.1 DiaCarta, Inc. Company Summary
7.18.2 DiaCarta, Inc. Business Overview
7.18.3 DiaCarta, Inc. Pharmacogenomics Services Major Product Offerings
7.18.4 DiaCarta, Inc. Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.18.5 DiaCarta, Inc. Key News & Latest Developments
7.19 OPKO Health
7.19.1 OPKO Health Company Summary
7.19.2 OPKO Health Business Overview
7.19.3 OPKO Health Pharmacogenomics Services Major Product Offerings
7.19.4 OPKO Health Pharmacogenomics Services Revenue in Global Market (2018-2023)
7.19.5 OPKO Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
